Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1454 ARTÍCULOS , VIENDO DEL 511 AL 525

Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study

Camargos EF, Louzada LL, Quintas JL, Naves JO, Louzada FM, Nóbrega OT.

Am J Geriatr Psychiatry. 2014 Dec;22(12):1565-74. doi: 10.1016/j.jagp.2013.12.174. Epub 2014 Jan 4.

The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease: a meta-analysis

Wei W, Xu X, Li H, Zhang Y, Han D, Wang Y, Yan W, Wang X, Zhang J, Liu N, You Y.

Neuromolecular Med. 2014 Jun;16(2):448-56. doi: 10.1007/s12017-014-8291-0. Epub 2014 Feb 5.

Chronic aluminum intake causes Alzheimer's disease: applying Sir Austin Bradford Hill's causality criteria

Walton JR.

J Alzheimers Dis. 2014;40(4):765-838. doi: 10.3233/JAD-132204.

Differences in nutritional status between very mild Alzheimer's disease patients and healthy controls

Olde Rikkert MG, Verhey FR, Sijben JW, Bouwman FH, Dautzenberg PL, Lansink M, Sipers WM, van Asselt DZ, van Hees AM, Stevens M, Vellas B, Scheltens P.

J Alzheimers Dis. 2014;41(1):261-71. doi: 10.3233/JAD-131892.

Differences in routine clinical practice between early and late onset Alzheimer's disease: data from the Swedish Dementia Registry (SveDem)

Eriksson H, Fereshtehnejad SM, Falahati F, Farahmand B, Religa D, Eriksdotter M.

J Alzheimers Dis. 2014;41(2):411-9. doi: 10.3233/JAD-132273.

Epidemiological genetics and meta-analysis of a polymorphism at codon 129 of the PRNP gene in Alzheimer's disease in Brazil

Pimentel LF, Gomes da Cunha JE, Morelato RL, de Paula F, de Oliveira JR.

Neurol Res. 2014 Sep;36(9):775-8. doi: 10.1179/1743132814Y.0000000332. Epub 2014 Feb 11.

Beyond acetylcholinesterase inhibitors for treating Alzheimer's disease: α7-nAChR agonists in human clinical trials

Russo P, Del Bufalo A, Frustaci A, Fini M, Cesario A.

Curr Pharm Des. 2014;20(38):6014-21. doi: 10.2174/1381612820666140316130720.

Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: the MEMAGE study

Gareri P, Putignano D, Castagna A, Cotroneo AM, De Palo G, Fabbo A, Forgione L, Giacummo A, Lacava R, Marino S, Simone M, Zurlo A, Putignano S.

J Alzheimers Dis. 2014;41(2):633-40. doi: 10.3233/JAD-132735.

The long reach of Alzheimer's disease: patients, practice, and policy

Bynum JP.

Health Aff (Millwood). 2014 Apr;33(4):534-40. doi: 10.1377/hlthaff.2013.1247.

Cardiopulmonary exercise testing is well tolerated in people with Alzheimer-related cognitive impairment

Billinger SA, Vidoni ED, Greer CS, Graves RS, Mattlage AE, Burns JM.

Arch Phys Med Rehabil. 2014 Sep;95(9):1714-8. doi: 10.1016/j.apmr.2014.04.007. Epub 2014 Apr 26.

Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease

Ringman JM, Sachs MC, Zhou Y, Monsell SE, Saver JL, Vinters HV.

JAMA Neurol. 2014 Jul 1;71(7):878-83. doi: 10.1001/jamaneurol.2014.681.

Is the Aluminum Hypothesis dead?

Lidsky TI.

J Occup Environ Med. 2014 May;56(5 Suppl):S73-9. doi: 10.1097/JOM.0000000000000063.

Atypical Alzheimer's disease in an elderly United States resident with amyotrophic lateral sclerosis and pathological tau in spinal motor neurons

McCluskey LF, Geser F, Elman LB, Van Deerlin VM, Robinson JL, Lee VM, Trojanowski JQ.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Sep;15(5-6):466-72. doi: 10.3109/21678421.2014.903973. Epub 2014 May 9.

Previously unrecognized missense mutation E126K of PSEN2 segregates with early onset Alzheimer's disease in a family

Müller U, Winter P, Bolender C, Nolte D.

J Alzheimers Dis. 2014;42(1):109-13. doi: 10.3233/JAD-140399.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias